Pharmacy benefit manager Express Scripts ESRX announced that it will include two new cholesterol lowering drugs Regeneron Sanofi’s REGN SNY Praluent and Amgen’s AMGN Repatha on its National Preferred Formulary. Both the drugs are first PCSK9 inhibitors that were